136 related articles for article (PubMed ID: 34446703)
1. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
[TBL] [Abstract][Full Text] [Related]
2. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells.
Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
[TBL] [Abstract][Full Text] [Related]
4. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
5. Mir-629 Repressed LATS2 Expression and Promoted the Proliferation of Prostate Cancer Cells.
Li Y; Zeng S; Cao L
Horm Metab Res; 2023 Aug; 55(8):573-579. PubMed ID: 36990459
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
Li H; Wang Y
Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
Yao F; Liu H; Li Z; Zhong C; Fang W
Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
[TBL] [Abstract][Full Text] [Related]
10. LINC01088 regulates the miR-95/LATS2 pathway through the ceRNA mechanism to inhibit the growth, invasion and migration of gastric cancer cells.
Wen Z; Li Y; Tan B; Chen Z; Zhao Q; Tan M; Zhao Y; Xia Y; FanΔ L
Int J Immunopathol Pharmacol; 2022; 36():3946320221108271. PubMed ID: 35728587
[No Abstract] [Full Text] [Related]
11. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation.
Cui Z; An X; Li J; Liu Q; Liu W
Biomed Pharmacother; 2018 Aug; 104():223-228. PubMed ID: 29775889
[TBL] [Abstract][Full Text] [Related]
13. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
[TBL] [Abstract][Full Text] [Related]
14. Identification and Functional Characterization of Long Non-coding RNA
Zhang DY; Zou XJ; Cao CH; Zhang T; Lei L; Qi XL; Liu L; Wu DH
Theranostics; 2018; 8(14):3751-3765. PubMed ID: 30083257
[TBL] [Abstract][Full Text] [Related]
15. MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
Feng S; Pan W; Jin Y; Zheng J
Tumour Biol; 2014 Dec; 35(12):12339-44. PubMed ID: 25179841
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
17. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
[TBL] [Abstract][Full Text] [Related]
18. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
19. MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
Fang L; Du WW; Yang W; Rutnam ZJ; Peng C; Li H; O'Malley YQ; Askeland RW; Sugg S; Liu M; Mehta T; Deng Z; Yang BB
Cell Cycle; 2012 Dec; 11(23):4352-65. PubMed ID: 23111389
[TBL] [Abstract][Full Text] [Related]
20. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
